1.Changes of balance between proteinase and their inhibitors in blood of pigs with high-velocity missile wounds.
Yuan-guo ZHOU ; Pei-fang ZHU ; Ji-hong ZHOU ; Xiao-yan LI
Chinese Journal of Traumatology 2003;6(4):222-225
OBJECTIVETo study the effect of imbalance between lysosomal enzymes and their inhibitors in blood on disturbance of the local and whole body after trauma.
METHODSThe dynamic changes of lysosomal enzymes and proteinase inhibitors were studied in 12 pigs with femoral comminuted fractures in both hind limbs caused by high velocity missiles. Four normal pigs served as controls.
RESULTSAfter injury, the activity of Cathepsin D in arterial plasma increased gradually and reached the highest level at 8 hours, acid phosphatase in serum began to increase at 12 hours and the value of serum elastase did not change significantly. The level of alpha1-antitrypsin, a proteinase inhibitor in plasma, decreased significantly in the early stage after injury [73.5%+/-6.4% and 81.0%+/-5.1% of the baseline value (1.67 micromol x ml(-1) x min(-1)+/- 0.29 micromol x ml(-1) x min(-1)) at l and 2 hours after injury, respectively, P<0.05], then increased gradually and was higher than the baseline value at 12 hours after injury.
CONCLUSIONSImbalance between lysosomal enzymes and proteinase inhibitors occurs soon after injury, which might result in continuous tissue damage and play an important role in the disturbance of general reaction after injury.
Acid Phosphatase ; blood ; Animals ; Cathepsin D ; blood ; Endopeptidases ; blood ; Female ; Lysosomes ; enzymology ; Male ; Pancreatic Elastase ; blood ; Swine ; Wounds, Gunshot ; blood ; alpha 1-Antitrypsin ; analysis
2.Plasma α1-antitrypsin: a neglected predictor of angiographic severity in patients with stable angina pectoris.
Hui ZHAO ; Hong LIU ; Lin CHAI ; Ping XU ; Lu HUA ; Xiao-Yuan GUAN ; Bing DUAN ; Yi-Ling HUANG ; Yi-Shi LI
Chinese Medical Journal 2015;128(6):755-761
BACKGROUNDAs an acute phase protein, α1-antitrypsin (AAT) has been extensively studied in acute coronary syndrome, but it is unclear whether a relationship exists between AAT and stable angina pectoris (SAP). The purpose of the present study was to investigate the association between AAT plasma levels and SAP.
METHODSOverall, 103 SAP patients diagnosed by coronary angiography and clinical manifestations and 118 control subjects matched for age and gender were enrolled in this case-control study. Plasma levels of AAT, high-sensitivity C-reactive protein (hsCRP), lipid profiles and other clinical parameters were assayed for all participants. The severity of coronary lesions was evaluated based on the Gensini score (GS) assessed by coronary angiography.
RESULTSPositively correlated with the GS (r = 0.564, P < 0.001), the plasma AAT level in the SAP group was significantly higher than that in the control group (142.08 ± 19.61 mg/dl vs. 125.50 ± 19.67 mg/dl, P < 0.001). The plasma AAT level was an independent predictor for both SAP (odds ratio [OR] = 1.037, 95% confidence interval [CI]: 1.020-1.054, P < 0.001) and a high GS (OR = 1.087, 95% CI: 1.051-1.124, P < 0.001) in a multivariate logistic regression model. In the receiver operating characteristic curve analysis, plasma AAT level was found to have a larger area under the curve (AUC) for predicting a high GS (AUC = 0.858, 95% CI: 0.788-0.929, P < 0.001) than that of hsCRP (AUC = 0.665, 95% CI: 0.557-0.773, P = 0.006; Z = 2.9363, P < 0.001), with an optimal cut-off value of 137.85 mg/dl (sensitivity: 94.3%, specificity: 68.2%).
CONCLUSIONSPlasma AAT levels correlate with both the presence and severity of coronary stenosis in patients with SAP, suggesting that it could be a potential predictive marker of severe stenosis in SAP patients.
Adult ; Aged ; Angina Pectoris ; blood ; diagnostic imaging ; Angina, Stable ; blood ; diagnostic imaging ; Case-Control Studies ; Coronary Angiography ; Female ; Humans ; Male ; Middle Aged ; alpha 1-Antitrypsin ; blood
3.Value of determination of haptoglobin and α1-antitrypsin in predicting response to glucocorticoid therapy in children with primary nephrotic syndrome.
Chinese Journal of Contemporary Pediatrics 2015;17(3):227-231
OBJECTIVETo study the value of the determination of serum and urine haptoglobin (HP) and alpha 1-antitrypsin (AAT) in predicting the response to glucocorticoid therapy in children with primary nephrotic syndrome (PNS).
METHODSA total of 84 children with PNS were classified to steroid-sensitive nephrotic syndrome (SSNS) (n=58) and steroid-resistant nephrotic syndrome (SRNS) groups (n=26). Forty healthy children were randomly selected for the control group. HP and AAT levels in blood and urinary samples were determined using ELISA. The efficiency of HP and AAT in predicting the response to glucocorticoid treatment of PNS was evaluated by the receiver operating characteristic (ROC) curve.
RESULTSCompared with the control group, both the SSNS and SRNS groups had significantly higher serum HP concentrations and urine AAT/Cr ratio before treatment (P<0.05); compared with the SSNS group, the SRNS group had significantly higher serum HP concentrations and urine AAT/Cr ratio before treatment and after one week and four weeks of treatment (P<0.05). Serum HP had the highest efficiency in predicting the response to glucocorticoid treatment of PNS at the concentration of 37.935 mg/mL, with the sensitivity and specificity being 92.3% and 86.2% respectively. Urine AAT/Cr ratio had the highest prediction efficiency at 0.0696, with the sensitivity and specificity being 100% and 79.3% respectively. ROC curve analysis of serum HP combined with urine AAT/Cr ratio showed a better prediction efficiency, with the sensitivity and specificity being 92.3% and 96.6% respectively.
CONCLUSIONSThe increase in serum HP level or urine AAT/Cr ratio may indicate glucocorticoid resistance in the early stage of PNS. A combination of the two can achieve better efficiency in the prediction of SRNS.
Child ; Child, Preschool ; Creatinine ; urine ; Female ; Glucocorticoids ; therapeutic use ; Haptoglobins ; analysis ; urine ; Humans ; Male ; Nephrotic Syndrome ; blood ; drug therapy ; urine ; alpha 1-Antitrypsin ; analysis ; blood ; urine
4.Correlation between pulmonary function impairment and levels of alpha1-antitrypsin in serum and colon of ulcerative colitis patients: a clinical research.
Jian-Yun WANG ; Xin-Yue WANG ; Hui-Yi SUN ; Da-Ming LIU ; Wen ZHANG ; Chen-Xi JIN ; Li LI ; Ling-Qun ZHU
Chinese Journal of Integrated Traditional and Western Medicine 2014;34(1):20-26
OBJECTIVETo explore the mechanism of pulmonary involvement in ulcerative colitis (UC) patients by observing the correlation between pulmonary functions and levels of alpha1-antitrypsin (A1AT) in serum and colon tissue in UC patients.
METHODSTotally 90 patients with confirmed UC were assigned to different groups according to the extent of disease, the disease activity, the staging of severity, and course of disease. The serum level of A1AT in UC patients with different extent of disease, the disease activity, the staging of severity, and course of disease were compared. And 30 healthy volunteers were recruited as the control group. The serum renal and hepatic functions, pulmonary functions, and serum levels of A1AT were detected in the UC group and the control group. The correlation between A1AT and each pulmonary function index in UC patients was analyzed. The A1AT content in the colon tissue was detected with immunohistochemical assay in 20 UC patients as well as in 10 healthy volunteers.
RESULTSOf the 90 UC patients, 54 patients were accompanied with pulmonary function abnormality (60.0%), and 24 with extraintestinal manifestations (26.7%). Compared with the control group, the serum level of A1AT was significantly lower in the UC group (P < 0.05). The serum level of A1AT was significantly higher in those with proctitis than in those with distal colonitis and pancolitis (P < 0.05). The serum level of A1AT was lower in patients with the course of disease 5 years and more than 5 years than in those with the course of disease less than 5 years (P < 0.05). Vital capacity (VC), forced vital capacity (FVC), forced expiratory volume in one second (FEV1.0), total lung capacity (TLC), function residual volume (FRV), and the ratio of diffusion capacity for carbon monoxide of lung (DLCO) were much lower in those with proctitis than in those with distal colonitis and pancolitis (P < 0.05). The ratio of FVC was negatively linear correlated with the course of disease (r = -0.23, P = 0.018). There was a positive correlation between the serum level of A1AT and peak expiratory flow (PEF) (r = 0.22, P = 0.03). The level of A1AT in the colon tissue was obviously lower in the UC patients than in those of the control group (P < 0.05). Mild and moderate UC patients had increased levels of A1AT in the colon tissue, when compared with severe UC patients (P < 0.05). The level of A1AT in the colon tissue was higher in those with proctitis than in those with distal colonitis and pancolitis (P < 0.05).
CONCLUSIONSThe prevalence of pulmonary function impairment was higher than other extraintestinal manifestations in UC patients. The pulmonary function test was helpful to screen the pulmonary impairment of UC patients. The A1AT level in the serum and the colon tissue obviously decreased in UC patients, indicating the pulmonary function impairment of UC patients might manifest as decreased A1AT levels correlated chronic airway inflammation, remodeling of airway, and obstructive changes.
Adult ; Aged ; Case-Control Studies ; Colitis, Ulcerative ; metabolism ; pathology ; physiopathology ; Colon ; metabolism ; Female ; Humans ; Lung ; physiopathology ; Male ; Middle Aged ; Young Adult ; alpha 1-Antitrypsin ; blood ; metabolism
5.A Case of Protein Loosing Enteropathy Associated with Pseudomembranous Colitis in a Patient with Peritonitis.
Gyoun Hong KWON ; Dong HEO ; Hyun Seung LEE ; Yong Gun JO ; Bong Jin KIM ; Jee Yeon KIM ; Yong Mock BAE
Korean Journal of Gastrointestinal Endoscopy 2008;37(3):227-230
Pseudomembranous colitis can be induced by the therapeutic or prophylactic use of antibiotics, and antibiotics- induced colitis has become a severe clinical problem. Protein?loosing enteropathy is associated with an abnormal, excessive loss of serum proteins into the gastrointestinal tract, and this leads to hypoproteinemia, including hypoalbuminemia, edema and diarrhea. We present here a case of protein?loosing enteropathy that was induced by pseudomembranous colitis, and this was induced by the use of antibiotics. Patients with chronic renal disease and peritonitis show hypoalbuminemia and edema. We experienced a patient who displayed edema, hypoalbuminemia, diarrhea and a fever for several days after the use for antibiotics for treating his peritonitis. We made the diagnosis of protein-loosing enteropathy complicated by psuedomembranous colitis. In a patient with peritonitis, uncontrolled edema and diarrhea, and the patient's hypoalbuminemia is continued, we must consider the possibility that the patient has protein-loosing enteropathy, and we should examine the total protein level and the alpha 1-antitrypsin clearance.
alpha 1-Antitrypsin
;
Anti-Bacterial Agents
;
Blood Proteins
;
Colitis
;
Diarrhea
;
Edema
;
Enterocolitis, Pseudomembranous
;
Fever
;
Gastrointestinal Tract
;
Humans
;
Hypoalbuminemia
;
Hypoproteinemia
;
Peritonitis
;
Renal Insufficiency, Chronic
6.Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B.
Hyo Jung CHO ; Soon Sun KIM ; Seun Joo AHN ; Joo Han PARK ; Dong Joon KIM ; Young Bae KIM ; Sung Won CHO ; Jae Youn CHEONG
Clinical and Molecular Hepatology 2014;20(4):347-354
BACKGROUND/AIMS: Transferrin and alpha-1 antitrypsin are reportedly associated with liver fibrosis. We evaluated the usefulness of serum transferrin and alpha-1 antitrypsin as new liver fibrosis markers in patients with chronic hepatitis B. METHODS: The study included 293 patients with chronic hepatitis B who underwent a liver biopsy between October 2005 and June 2009, and who had no history of hepatocellular carcinoma. Serum markers and liver fibrosis stages were compared. RESULTS: Univariate analysis revealed that age (P<0.001), serum platelet count (P<0.001), and serum alkaline phosphatase level (P=0.003) differed significantly between the patients with and without liver cirrhosis. Serum transferrin levels were significantly lower in advanced fibrosis than in mild fibrosis in both univariate analysis (P=0.002) and multivariate analysis (P=0.009). In addition, the serum transferrin level was significantly lower in cirrhotic patients than in noncirrhotic patients (P=0.020). However, the serum level of alpha-1 antitrypsin was not significantly associated with liver cirrhosis in patients with chronic hepatitis B. CONCLUSIONS: Serum transferrin could be promising serum marker for predicting advanced liver fibrosis in patients with chronic hepatitis B.
Adolescent
;
Adult
;
Aged
;
Area Under Curve
;
Biological Markers/blood
;
Female
;
Hepatitis B, Chronic/complications/*diagnosis/pathology
;
Humans
;
Liver Cirrhosis/complications/*diagnosis
;
Male
;
Middle Aged
;
Multivariate Analysis
;
ROC Curve
;
Retrospective Studies
;
Transferrins/*blood
;
Young Adult
;
alpha 1-Antitrypsin/blood
7.Clinical usefulness of alpha-1-antitrypsin in the diagnosis of hepatocellular carcinoma.
Journal of Korean Medical Science 1991;6(3):206-213
Serum levels of alpha-1-Antitrypsin(AAT) were determined in 42 patients with hepatocellular carcinoma(HCC), 5 patients with metastatic liver cancer from stomach adenocarcinoma, 10 patients with liver cirrhosis, 10 patients with chronic hepatitis, and 66 controls by rocket immunoelectrophoresis using rabbit antiserum. The mean level of serum AAT was 225.5 +/- 73.0 mg/dl in 66 controls. The serum AAT in patients with HCC was 428.7 +/- 123.3 mg/dl, which was significantly higher than those in the controls and in patients with liver cirrhosis or chronic hepatitis(p less than 0.02). The level of AAT in metastatic liver cancer was similar to that in HCC. The positive cut-off value for elevation of serum AAT in this study was determined as above 445 mg/dl, the mean plus 3 standard deviations in the controls. Elevations of serum AAT were observed in 54.8%, 60.0%, and 10.0% of patients with HCC, metastatic liver cancer, and liver cirrhosis, respectively, while none of the patients with chronic hepatitis or the controls was positive. The serum AAT levels in 42 patients with HCC were analyzed with regard to sex, age, serum albumin, HBsAg, alpha-fetoprotein(AFP), and diameter of HCC, with no significant differences being observed between these factors and the serum AAT levels except for the diameter of the HCC. The positive rate in the HCC with a diameter of 10 cm or more was 74.1%, which was a significantly higher rate compared with 20.0% in the HCC with diameters less than 10cm. The positive rate of AFP for HCC was 61.9%, when 500 ng/ml of AFP was used as the cut-off value.(ABSTRACT TRUNCATED AT 250 WORDS)
Adult
;
Aged
;
Carcinoma, Hepatocellular/blood/*diagnosis
;
False Negative Reactions
;
False Positive Reactions
;
Female
;
Humans
;
Liver Neoplasms/blood/*diagnosis
;
Male
;
Middle Aged
;
Tumor Markers, Biological/*blood
;
alpha 1-Antitrypsin/*analysis
8.Proteomic Profiling of Serum from Patients with Tuberculosis.
Sang Hoon SONG ; Minje HAN ; Yang Seon CHOI ; Ki Soon DAN ; Man Gil YANG ; Junghan SONG ; Sung Sup PARK ; Jae Ho LEE
Annals of Laboratory Medicine 2014;34(5):345-353
BACKGROUND: Effective treatment and monitoring of tuberculosis (TB) requires biomarkers that can be easily evaluated in blood samples. The aim of this study was to analyze the serum proteome of patients with TB and to identify protein biomarkers for TB. METHODS: Serum samples from 26 TB patients and 31 controls were analyzed by using nano-flow ultra-performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry in data-independent mode, and protein and peptide amounts were calculated by using a label-free quantitative approach. The generated data were analyzed by using principal component analysis and partial least squares discriminant analysis, a multivariate statistical method. RESULTS: Of more than 500 proteins identified, alpha-1-antitrypsin was the most discriminative, which was 4.4 times higher in TB patients than in controls. Peptides from alpha-1-antitrypsin and antithrombin III increased in TB patients and showed a high variable importance in the projection scores and coefficient in partial least square discriminant analysis. CONCLUSIONS: Sera from patients with TB had higher alpha-1-antitrypsin levels than sera from control participants. Alpha-1-antitrypsin levels may aid in the diagnosis of TB.
Adult
;
Aged
;
Antithrombin III/analysis
;
Biological Markers/blood
;
Chromatography, High Pressure Liquid
;
Discriminant Analysis
;
Female
;
Humans
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Proteome/*analysis
;
*Proteomics
;
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
;
Tuberculosis/*blood/genetics/metabolism
;
alpha 1-Antitrypsin/analysis
9.Effect of Dansen injection on experimental emphysema in rabbits.
Lan-Ping GUO ; Zhi-Gang WANG ; Biao LIANG ; Bin WU ; Ai-Lian ZHOU ; Bo PENG
China Journal of Chinese Materia Medica 2005;30(15):1188-1191
OBJECTIVETo observe the effect of Dansen injection on the experimental emphysema in rabbits.
METHODThirty-six rabbits were randomized into emphysema group (n = 12), Dansen injection treated group (n = 12) and alpha1-antitrypsin(alpha1-AT) treated group (n = 12). The animal model of emphysema was induced by intratracheal instillation of porcine pancreatic elastase. Dansen injection and alpha1-ATwere instilled intratracheal in two treated group after 14 days with porcine pancreatic elastase, respectively, once a week, to continue for four weeks. The level of alpha1-AT in serum and in bronchoalveolar lavage fluid (BALF) were analyzed in different times. The mean linear intercept value (MLIV) and the numbers of alveolar per square (NAPS) of all groups were compared after eight weeks with porcine pancreatic elastase.
RESULTThe levels of alpha1-AT in BALF were significantly different between treated groups and emphysema group after two weeks treatment, alpha1-AT levels of treated groups were more increased than those of emphysema group (P < 0.01). The levels of alpha1-AT in serum were similar at same times in different groups (P > 0.05), but were great different in different times. The MLIV and the NAPS were significantly different from emphysema group to treated groups in sixth and eighth weeks (P < 0.01), there is no difference between dancen group and alpha1-AT group.
CONCLUSIONThe contents of alpha1-AT in local pulmonary tissue could be improved by Dansen injection through intratracheal instillation during the information of emphysema in rabbits. The effect of Dansen injection and alpha1-AT on preventing formation of emphysema is similar.
Animals ; Bronchoalveolar Lavage Fluid ; chemistry ; Drugs, Chinese Herbal ; administration & dosage ; isolation & purification ; pharmacology ; Injections ; Lung ; pathology ; Male ; Pancreatic Elastase ; Plants, Medicinal ; chemistry ; Pulmonary Emphysema ; chemically induced ; metabolism ; pathology ; Rabbits ; Random Allocation ; Salvia miltiorrhiza ; chemistry ; alpha 1-Antitrypsin ; blood ; metabolism ; pharmacology
10.An overview of biomarkers in Alzheimer's disease.
Xian-Fang RONG ; Xiao-Liang WANG
Acta Pharmaceutica Sinica 2012;47(5):551-557
Alzheimer's disease (AD), also called presenile dementia, is one of the most common neurodegenerative diseases in elderly people. The main pathological features of AD include senile plaques (SPs), neurofibrillary tangles (NFTs) and neuron loss. A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacological responses to a therapeutic intervention. Class biomarkers of AD such as Abeta and phosphorylated tau have been widely used in clinical diagnosis of AD patients. Recently, novel technologies like proteomics, genomics, and imaging techniques have expanded the role of a biomarker from early diagnosis to monitoring the progression of diseases and evaluating the response to various treatments. In this article, we will review the progress of various biomarkers of AD.
Adipokines
;
cerebrospinal fluid
;
Alzheimer Disease
;
cerebrospinal fluid
;
diagnosis
;
diagnostic imaging
;
metabolism
;
Amyloid beta-Peptides
;
cerebrospinal fluid
;
Biomarkers
;
analysis
;
Chitinase-3-Like Protein 1
;
Fluorodeoxyglucose F18
;
Humans
;
Lectins
;
cerebrospinal fluid
;
Peptide Fragments
;
cerebrospinal fluid
;
Phosphorylation
;
Positron-Emission Tomography
;
Presenilins
;
analysis
;
alpha 1-Antitrypsin
;
blood
;
tau Proteins
;
cerebrospinal fluid